Raymond James Downgrades Compass Therapeutics (CMPX) to Market Perform
Tweet Send to a Friend
(Updated - April 28, 2026 6:24 AM EDT)
Raymond James analyst Sean McCutcheon downgraded Compass Therapeutics (NASDAQ: CMPX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Sean McCutcheon downgraded Compass Therapeutics (NASDAQ: CMPX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
